Viatris (VTRS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks
Apri Zacks
Viatris (VTRS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Wall Street analysts forecast that Viatris (VTRS) will report quarterly earnings of $0.64 per share in its upcoming release, pointing to a year-over-year decline of 4.5%. It is anticipated that revenues will amount to $3.78 billion, exhibiting an increase of 0.5% compared to the year-ago quarter.

The consensus EPS estimate for the quarter has been revised 0.4% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

With that in mind, let's delve into the average projections of some Viatris metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts predict that the 'Net Sales- Developed Markets' will reach $2.23 billion. The estimate indicates a change of -1.2% from the prior-year quarter.

Analysts forecast 'Net Sales- Greater China' to reach $675.37 million. The estimate indicates a change of +9.8% from the prior-year quarter.

The combined assessment of analysts suggests that 'Net Sales- JANZ' will likely reach $291.56 million. The estimate suggests a change of -4.8% year over year.

Based on the collective assessment of analysts, 'Net Sales- Emerging Markets' should arrive at $565.37 million. The estimate points to a change of -0.9% from the year-ago quarter.

It is projected by analysts that the 'Net Sales- Developed Markets- Brands' will reach $1.24 billion. The estimate indicates a change of -0.5% from the prior-year quarter.

The consensus estimate for 'Net Sales- Developed Markets- Generics' stands at $992.94 million. The estimate indicates a year-over-year change of -2.1%.

According to the collective judgment of analysts, 'Revenues- Other revenues' should come in at $10.27 million. The estimate indicates a year-over-year change of -17.2%.

The collective assessment of analysts points to an estimated 'Net Sales- JANZ- Generics' of $147.72 million. The estimate indicates a change of +0.4% from the prior-year quarter.

Analysts' assessment points toward 'Net Sales- Emerging Markets- Brands' reaching $452.44 million. The estimate suggests a change of +6.7% year over year.

The average prediction of analysts places 'Net Sales- Emerging Markets- Generics' at $112.93 million. The estimate indicates a change of -22.8% from the prior-year quarter.

Analysts expect 'Net Sales- JANZ- Brands' to come in at $143.85 million. The estimate indicates a change of -9.6% from the prior-year quarter.

The consensus among analysts is that 'Revenues- Total Net Sales' will reach $3.76 billion. The estimate suggests a change of +0.4% year over year.

View all Key Company Metrics for Viatris here>>>

Over the past month, Viatris shares have recorded returns of +7.9% versus the Zacks S&P 500 composite's -2% change. Based on its Zacks Rank #3 (Hold), VTRS will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Viatris Inc. (VTRS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research